VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY. (17th June 2021) - Al‐Sawaf, O.; Zhang, C.; Robrecht, S.; Tandon, M.; Panchal, A.; Fink, A.‐M.; Tausch, E.; Ritgen, M.; Kreuzer, K.‐A.; Kim, S.; Wendtner, C.; Eichhorst, B.; et al.